Comparison

CardiAction vs Traditional Tests

Discover the future of heart health screening by predicting elevated central systolic blood pressure (cSBP) accurately; the leading indicator of cadiovascular events, including heart attacks and strokes.

Screening Methods
No Lab Visit Required And Inexpensive
Instant results
Simple, Easy, Available Online, Anytime
User-friendly interface
Simple and inexpensive procedures
CardiAction Screening

Non-invasive and efficient

Blood Test Screening

Invasive and time-consuming

Screening

Three ways to deploy CardiAction

Health Screening Service Providers
License API to CardiAction model to power any website or mobile app
License CardiAction platform health screener module
CardiAction mobile app (optional)
Mass Population Screening
License API to CardiAction model to power any website or mobile app
CardiAction mobile app (optional)
White Labelling Option
Please contact to discuss

CardiAction Nationwide Impact: transforming health across New Zealand

Eliminating the need for a blood test allows for patients to regularly review their CVD risk score progress against their targets with their HCP.

Our NZ trial indicates that when combined with scientifically backed interventions via our app, it can be highly motivating over a longer period, helping to deliver true long term changes.

Empowering New Zealanders Through Pharmacy-Led Cardiovascular Screening:
‍
To improve access to cardiovascular risk screening, Health Screening NZ partnered with CardiAction and Green Cross Health pharmacies to introduce a comprehensive, pharmacy-based cardiovascular screening service

Heart and artery health: The future of cardiovascular screening awaits you

Breaking barriers for vulnerable communities

CardiAction brings critical screening services to Indigenous populations and low socioeconomic groups, where access to traditional healthcare is often limited due to cultural, financial, or geographical barriers.

The screening is non-invasive and does not require blood tests, making it culturally appropriate and accessible to underserved populations.

CardiAction brings critical screening services to Indigenous populations and low socioeconomic groups, where access to traditional healthcare is often limited due to cultural, financial, or geographical barriers.

The screening is non-invasive and does not require blood tests, making it culturally appropriate and accessible to underserved populations.

Testimonials

Don’t take our word for it! Hear it from our partners

The team was incredible! They were knowledgeable, friendly, and always willing to help. I felt supported throughout the entire process, and I am thrilled with the results.

Chris Lee
Position, Company name

The service provided was top-notch. Every detail was taken care of, and I felt valued as a customer. I am very pleased with the outcome and will recommend them to others.

Sarah Brown
Position, Company name

I had a fantastic experience from start to finish. The communication was clear, and the final product exceeded my expectations. I will definitely be returning for future projects.

David Wilson
Position, Company name

The results we achieved were excellent. The team worked tirelessly to ensure everything was perfect, and their expertise made a significant difference in our project.

Emily Davis
Position, Company name

I highly recommend this company! Their attention to detail and commitment to customer satisfaction is unmatched. They truly care about their clients and it shows in their work.

Michael Johnson
Position, Company name
Resources

Supported by Science & Research

Current CVD Global Stats
View
Approx. 50% of people admitted to hospital with CVD have Normal Cholesterol Levels
View
Inflammation not Cholesterol is the Root Cause of CVD
View
Brachial Cuff BP Testing Devices
View
In-Clinic BP Testing
View
Efficacy of Current Methods for Screening of CVD
Risk Factors
View
Central Aortic Pulse Wave Analysis (CAPWA) Technology
View
Accuracy of fully automated oscillometric central aortic blood pressure measurement techniques
View
Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure
View
Vascular ageing: moving from bench towards bedside
View
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
View
Current CVD Global Stats
View
Approx. 50% of people admitted to hospital with CVD have Normal Cholesterol Levels
View
Inflammation not Cholesterol is the Root Cause of CVD
View
Brachial Cuff BP Testing Devices
View
In-Clinic BP Testing
View
Efficacy of Current Methods for Screening of CVD
Risk Factors
View
Central Aortic Pulse Wave Analysis (CAPWA) Technology
View
Accuracy of fully automated oscillometric central aortic blood pressure measurement techniques
View
Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure
View
Vascular ageing: moving from bench towards bedside
View
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
View
Current CVD Global Stats
View
Approx. 50% of people admitted to hospital with CVD have Normal Cholesterol Levels
View
Inflammation not Cholesterol is the Root Cause of CVD
View
Brachial Cuff BP Testing Devices
View
In-Clinic BP Testing
View
Efficacy of Current Methods for Screening of CVD
Risk Factors
View
Central Aortic Pulse Wave Analysis (CAPWA) Technology
View
Accuracy of fully automated oscillometric central aortic blood pressure measurement techniques
View
Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure
View
Vascular ageing: moving from bench towards bedside
View
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
View
Current CVD Global Stats
View
Approx. 50% of people admitted to hospital with CVD have Normal Cholesterol Levels
View
Inflammation not Cholesterol is the Root Cause of CVD
View
Brachial Cuff BP Testing Devices
View
In-Clinic BP Testing
View
Efficacy of Current Methods for Screening of CVD
Risk Factors
View
Central Aortic Pulse Wave Analysis (CAPWA) Technology
View
Accuracy of fully automated oscillometric central aortic blood pressure measurement techniques
View
Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure
View
Vascular ageing: moving from bench towards bedside
View
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
View
Current CVD Global Stats
View
Approx. 50% of people admitted to hospital with CVD have Normal Cholesterol Levels
View
Inflammation not Cholesterol is the Root Cause of CVD
View
Brachial Cuff BP Testing Devices
View
In-Clinic BP Testing
View
Efficacy of Current Methods for Screening of CVD
Risk Factors
View
Central Aortic Pulse Wave Analysis (CAPWA) Technology
View
Accuracy of fully automated oscillometric central aortic blood pressure measurement techniques
View
Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure
View
Vascular ageing: moving from bench towards bedside
View
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
View
Current CVD Global Stats
View
Approx. 50% of people admitted to hospital with CVD have Normal Cholesterol Levels
View
Inflammation not Cholesterol is the Root Cause of CVD
View
Brachial Cuff BP Testing Devices
View
In-Clinic BP Testing
View
Efficacy of Current Methods for Screening of CVD
Risk Factors
View
Central Aortic Pulse Wave Analysis (CAPWA) Technology
View
Accuracy of fully automated oscillometric central aortic blood pressure measurement techniques
View
Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure
View
Vascular ageing: moving from bench towards bedside
View
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
View

We're here to help you

Have questions? Our team is ready to assist you with your cardiovascular health inquiries.

Quick Links
Legal
Socials
Quick Links
Socials
Legal
Copyright © 2025 CardiAction
Copyright © 2025 CardiAction